Materias dentro de su búsqueda.
Mostrando 485,101 - 485,120 Resultados de 487,202 Para Buscar '"free will"', tiempo de consulta: 2.33s Limitar resultados
  1. 485101
    por Tang, Siyu
    Publicado 2022
    “…On the other hand, one of the features of QCD, the asymptotic freedom, tells us that the free quarks and gluons can be produced in an environment of extreme high temperatures and/or high densities, which results in a new phase of matter, the quark–gluon plasma (QGP). …”
    Enlace del recurso
    Measurements of muons from open heavy-flavour hadron decays and jet particles in p-Pb and Pb-Pb collisions with ALICE at the LHC
  2. 485102
    por CERN. Geneva
    Publicado 2023
    “…</i><br><i>The conference is based on his latest book: "</i>Physics in Crises, from Multiverse to fake news<i>" (L'Harmattan)</i></p><p><i>Conference in French only | Free entrance, registration recommended</i></p><p><i>A recording will be available online after the event</i></p>…”
    Enlace del recurso
    Physique en questions - Des multivers aux fake-news
  3. 485103
    “…At this meeting it was decided to concentrate the efforts on two radionuclides, 188Re and 90Y, which are produced by generator systems and result in carrier free products; lanreotide was selected as a model peptide. …”
    Enlace del recurso
    Labelling techniques of biomolecules for targeted radiotherapy: final report of a co-ordinated research project 1998-2002
  4. 485104
    por Assmann, R W, Weikum, M K, Akhter, T, Alesini, D, Alexandrova, A S, Anania, M P, Andreev, N E, Andriyash, I, Artioli, M, Aschikhin, A, Audet, T, Bacci, A, Barna, I F, Bartocci, S, Bayramian, A, Beaton, A, Beck, A, Bellaveglia, M, Beluze, A, Bernhard, A, Biagioni, A, Bielawski, S, Bisesto, F G, Bonatto, A, Boulton, L, Brandi, F, Brinkmann, R, Briquez, F, Brottier, F, Bründermann, E, Büscher, M, Buonomo, B, Bussmann, M H, Bussolino, G, Campana, P, Cantarella, S, Cassou, K, Chancé, A, Chen, M, Chiadroni, E, Cianchi, A, Cioeta, F, Clarke, J A, Cole, J M, Costa, G, Couprie, M -E, Cowley, J, Croia, M, Cros, B, Crump, P A, D'Arcy, R, Dattoli, G, Del Dotto, A, Delerue, N, Del Franco, M, Delinikolas, P, De Nicola, S, Dias, J M, Di Giovenale, D, Diomede, M, Di Pasquale, E, Di Pirro, G, Di Raddo, G, Dorda, U, Erlandson, A C, Ertel, K, Esposito, A, Falcoz, F, Falone, A, Fedele, R, Ferran Pousa, A, Ferrario, M, Filippi, F, Fils, J, Fiore, G, Fiorito, R, Fonseca, R A, Franzini, G, Galimberti, M, Gallo, A, Galvin, T C, Ghaith, A, Ghigo, A, Giove, D, Giribono, A, Gizzi, L A, Grüner, F J, Habib, A F, Haefner, C, Heinemann, T, Helm, A, Hidding, B, Holzer, B J, Hooker, S M, Hosokai, T, Hübner, M, Ibison, M, Incremona, S, Irman, A, Iungo, F, Jafarinia, F J, Jakobsson, O, Jaroszynski, D A, Jaster-Merz, S, Joshi, C, Kaluza, M, Kando, M, Karger, O S, Karsch, S, Khazanov, E, Khikhlukha, D, Kirchen, M, Kirwan, G, Kitégi, C, Knetsch, A, Kocon, D, Koester, P, Kononenko, O S, Korn, G, Kostyukov, I, Kruchinin, K O, Labate, L, Le Blanc, C, Lechner, C, Lee, P, Leemans, W, Lehrach, A, Li, X, Li, Y, Libov, V, Lifschitz, A, Lindstrøm, C A, Litvinenko, V, Lu, W, Lundh, O, Maier, A R, Malka, V, Manahan, G G, Mangles, S P D, Marcelli, A, Marchetti, B, Marcouillé, O, Marocchino, A, Marteau, F, Martinez de la Ossa, A, Martins, J L, Mason, P D, Massimo, F, Mathieu, F, Maynard, G, Mazzotta, Z, Mironov, S, Molodozhentsev, A Y, Morante, S, Mosnier, A, Mostacci, A, Müller, A -S, Murphy, C D, Najmudin, Z, Nghiem, P A P, Nguyen, F, Niknejadi, P, Nutter, A, Osterhoff, J, Oumbarek Espinos, D, Paillard, J -L, Papadopoulos, D N, Patrizi, B, Pattathil, R, Pellegrino, L, Petralia, A, Petrillo, V, Piersanti, L, Pocsai, M A, Poder, K, Pompili, R, Pribyl, L, Pugacheva, D, Reagan, B A, Resta-Lopez, J, Ricci, R, Romeo, S, Rossetti Conti, M, Rossi, A R, Rossmanith, R, Rotundo, U, Roussel, E, Sabbatini, L, Santangelo, P, Sarri, G, Schaper, L, Scherkl, P, Schramm, U, Schroeder, C B, Scifo, J, Serafini, L, Sharma, G, Sheng, Z M, Shpakov, V, Siders, C W, Silva, L O, Silva, T, Simon, C, Simon-Boisson, C, Sinha, U, Sistrunk, E, Specka, A, Spinka, T M, Stecchi, A, Stella, A, Stellato, F, Streeter, M J V, Sutherland, A, Svystun, E N, Symes, D, Szwaj, C, Tauscher, G E, Terzani, D, Toci, G, Tomassini, P, Torres, R, Ullmann, D, Vaccarezza, C, Valléau, M, Vannini, M, Vannozzi, A, Vescovi, S, Vieira, J M, Villa, F, Wahlström, C -G, Walczak, R, Walker, P A, Wang, K, Welsch, A, Welsch, C P, Weng, S M, Wiggins, S M, Wolfenden, J, Xia, G, Yabashi, M, Zhang, H, Zhao, Y, Zhu, J, Zigler, A
    Publicado 2020
    “…The foreseen electron energy range of one to five gigaelectronvolts (GeV) and its performance goals will enable versatile applications in various domains, e.g. as a compact free-electron laser (FEL), compact sources for medical imaging and positron generation, table-top test beams for particle detectors, as well as deeply penetrating X-ray and gamma-ray sources for material testing. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    EuPRAXIA Conceptual Design Report
  5. 485105
    “…Due to the pandemic caused by COVID-19 worldwide, it is necessary to rethink the way of producing vegetables taking advantage of free spaces at homes, since a large majority of the world's population has lost their jobs, and they need to generate income for their families. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo
    Yield evaluation of lettuce grown in three modified NFT systems in pandemic times
  6. 485106
    “…The proposal is based on strengthening Mexico’s competitive advantage as a producer of free chemical coffee, in areas such as: a) promoting coffee quality, through the assimilation of technologies that allow the recovery of the coffee plantations b) diffusion of inherited practices, proven by farmers and producers in the management of coffee plantation, which favor the preservation of its territory and microenvironments, against the implementation of actions taken by the federal government such as the exchange of “tolerant to rust” varieties grown in semi-open field, involving the rapid and irreversible destruction of forest ecosystems in Mexico and the world.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo
    Proposals for the preservation of life in coffee plantations in Teocelo, Veracruz
  7. 485107
    “…IN THIS SECOND DOCUMENT, PROCEDURES FOR CREATION AND COMPRESSION OF PRE CONSTRUCTED INDEXES ARE PRESENTED, AS WELL AS RETRIEVAL FILES FOR WORD FREE-SEARCHING. SOME TECHNIQUES FOR CREATION AND RETRIEVAL OF BOTH ACCESS PATHS ARE FULLY DISCUSSED. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo
    Specialized algorithms for the storage and retrieval of bibliographic information (Second of two parts)
  8. 485108
    “…Secondary objectives included overall response rate (ORR), safety, progression free survival (PFS), and duration of response (DoR). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma
  9. 485109
    “…RESULTS: In vitro TMZ sensitivity of patient-derived GSCs classified patients into groups with different survival outcomes (P = 1.12e−4 for progression-free survival (PFS) and 3.63e−4 for overall survival (OS)). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
  10. 485110
    “…The primary endpoint was the objective response rate (ORR), and the secondary endpoints comprised disease control rate (DCR), duration of response (DoR), progression-free survival (PFS), overall survival (OS), and safety. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
  11. 485111
    “…A higher UCEIS at baseline was negatively associated with clinical response [adjusted odds ratio (aOR): 0.774, p = 0.029] and corticosteroid-free clinical response (aOR: 0.782, p = 0.035) at week 52. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  12. 485112
    Publicado 2023
    “…With a median follow-up period of 18.6 months, the probabilities of relapse-free survival（RFS）and overall survival（OS）at 3 years were 25.4％ and 37.3％ in patients with transplantation, and in patients with chemotherapy, the probabilities of RFS and OS at 3-year were 58.2％ and 64.3％, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    继发性急性髓系白血病的治疗反应和结局及其影响因素分析
  13. 485113
    “…Cardiac-sparing irradiation using the deep inspiration breath-hold (DIBH) technique can achieve substantial dose reduction to vulnerable cardiac substructures compared with free breathing (FB). This study evaluated the dosimetric differences between both techniques at a single institution. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses
  14. 485114
    “…In patients with mCRPC, the objective response rate (ORR, 95% CI) was 5.6% (1.2% to 15.4%) and the median radiographic progression-free survival (rPFS) was 5.6 (3.5 to not estimable) months for all; the ORR was 16.7% (3.6% to 41.4%) and 6-month rPFS rate was 45.5% (24.9% to 64.1%) for those who received RP2D with measurable disease (n=18). 7.4% of patients with mCRPC achieved a ≥50% decline in baseline PSA (PSA-50), with a median duration of 4.6 (1.2–45.2) months. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
  15. 485115
    “…METHODS: A partitioned survival analyses model was developed including three health states: progression free, progressed, and death. A cycle length of 28 days and a time horizon of 10 years was assumed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada
  16. 485116
    “…Both rheumatoid arthritis and psoriasis patients demonstrated the shortest disease-free survival rates (2.9y ± 1.1, 2.3y ± 0.7, respectively), compared to controls (4.1y ± 2.8) and to all other IS groups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients—A Comparison between Different Immunomodulating Conditions
  17. 485117
    “…METHODS: Participants without heart failure (HF) who had undergone cardiac magnetic resonance (CMR) to measure EAT thickness over the right ventricular free wall from the Framingham Heart Study were included. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain
  18. 485118
    “…Ninety-four one-day-old laying chickens underwent free feeding and drinking water for three days. Then, fourteen laying chickens were randomly selected as the control group, and sixteen laying chickens were selected as the model group. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Study on the Hepatoprotective Effect Mechanism of Polysaccharides from Charred Angelica sinensis on the Layer Chickens Based on the Detection of the Intestinal Floras and Short-Chain Fatty Acids of Cecal Contents and Association Analysis
  19. 485119
    “…DIP2B expression predicted reduced disease-free survival and OS in BRCA patients (each P < 0.05), especially those with the Her-2 + subtype (P = 0.023 and P = 0.069). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer
  20. 485120
    por Orlow, Irene, Sadeghi, Keimya D., Edmiston, Sharon N., Kenney, Jessica M., Lezcano, Cecilia, Wilmott, James S., Cust, Anne E., Scolyer, Richard A., Mann, Graham J., Lee, Tim K., Burke, Hazel, Jakrot, Valerie, Shang, Ping, Ferguson, Peter M., Boyce, Tawny W., Ko, Jennifer S., Ngo, Peter, Funchain, Pauline, Rees, Judy R., O’Connell, Kelli, Hao, Honglin, Parrish, Eloise, Conway, Kathleen, Googe, Paul B., Ollila, David W., Moschos, Stergios J., Hernando, Eva, Hanniford, Douglas, Argibay, Diana, Amos, Christopher I., Lee, Jeffrey E., Osman, Iman, Luo, Li, Kuan, Pei-Fen, Aurora, Arshi, Gould Rothberg, Bonnie E., Bosenberg, Marcus W., Gerstenblith, Meg R., Thompson, Cheryl, Bogner, Paul N., Gorlov, Ivan P., Holmen, Sheri L., Brunsgaard, Elise K., Saenger, Yvonne M., Shen, Ronglai, Seshan, Venkatraman, Nagore, Eduardo, Ernstoff, Marc S., Busam, Klaus J., Begg, Colin B., Thomas, Nancy E., Berwick, Marianne
    Publicado 2023
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma
Herramientas de búsqueda: RSS